Hexagon
Biotech company using genomics and AI to discover novel small-molecule medicines from microbial genomes.
About
Hexagon Bio is a biopharmaceutical company that leverages a proprietary interdisciplinary platform combining machine learning, genomics, synthetic biology, and automation. They mine microbial genomes to discover and develop structurally diverse small-molecule therapeutics for oncology and infectious diseases. Teams look it up for AI, Biotech, Drug Discovery.
Frequently asked
What does Hexagon do?
Hexagon is an AI company that offers Software. Teams look it up for Biotech, Drug Discovery. It is based in Menlo Park, United States and was founded in 2017. Public records show about 67 people and $61M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Hexagon raised?
Hexagon has raised a total of $61M in funding. The most recent round on record is Series A.
Where is Hexagon headquartered?
Hexagon is headquartered in Menlo Park, United States.
When was Hexagon founded?
Hexagon was founded in 2017.
What industry does Hexagon operate in?
Hexagon operates in AI, Biotech, Drug Discovery.
How many employees does Hexagon have?
Hexagon has approximately 67 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.